The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Exelon



Novartis Europharm LimitedEU/1/98/066/027-030

Main Information

Trade NameExelon
Active SubstancesRivastigmine
Dosage FormTransdermal patch
Licence HolderNovartis Europharm Limited
Licence NumberEU/1/98/066/027-030

Group Information

ATC CodeN06DA Anticholinesterases
N06DA03 rivastigmine

Status

License statusAuthorised
Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Educational Materials - Patient

« Back